search
insulin
Trends
- 1Iran faces shortages of 800 medicines amid sanctions and war costs●A Hebrew newspaper reports that US sanctions, inflation, currency shortages, and the costs of war have exacerbated Iran'
A Hebrew newspaper reports that Iran's pharmaceutical crisis has worsened, with shortages affecting roughly 800 types of medication, including drugs for cancer, heart conditions, migraines and insulin. The report attributes the crisis to US sanctions, high inflation, currency shortages and the financial burden of war, leaving patients struggling to obtain essential treatments.
- 2Pancreatic Cells One Genetic Tweak From Treating Diabetes▼Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https:// fed.brid.gy/r/https://www.wire d.c
New research suggests some pancreatic cells could be converted into insulin-producing cells with a single genetic modification, offering a promising avenue for diabetes treatment. The findings, reported by Wired, point to the potential of reprogramming existing cells to restore insulin function in patients. Scientists and health watchers are sharing the story as a possible step toward new therapies for the disease.
- 3The End of Insulin Injections? Scientists Push Needle-Free Medicine▼The End of Insulin Injections? How Scientists Are Making Medicine Needle-Free
Scientists are developing needle-free ways to deliver medicine, including insulin, with the goal of replacing traditional injections for millions of patients, particularly people with diabetes. The work, highlighted by National Geographic, covers new technologies that could deliver drugs through the skin or other routes without needles. If successful, the approach could reduce pain and needle anxiety for patients who need daily injections.
- 4Pancreatic Cells One Genetic Tweak From Treating Diabetes●Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https://www.wired.com/story/pancreatic-cell
New research reported by Wired suggests some pancreatic cells could be converted into insulin-producing cells through a single genetic modification, offering a potential new avenue for treating diabetes. The findings point to reprogramming existing cells rather than replacing them, a possibility researchers say could one day change how the disease is managed.
- 5Israeli startup wins FDA clearance for injection-based diabetes app●Israeli startup develops injection-based diabetes app, receives FDA clearance
An Israeli startup has received US Food and Drug Administration clearance for an app designed to support people managing diabetes with injections. The digital tool is aimed at helping patients track and handle their insulin treatment more effectively. The clearance marks a regulatory milestone for the young company, and coverage in Israeli media highlights it as another example of the country's health-tech sector gaining traction abroad.
- 6FDA approves Onswik, a once-weekly insulin for type 2 diabetes●The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the s
The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.
- 7New questions raised in killer nurse Colin Norris case●Murder or medical mix-up? New questions in the case of killer nurse Colin Norris https://www.bbc.co.uk/news/articles/ckg
Fresh scrutiny has emerged over the convictions of Colin Norris, the UK nurse jailed in 2008 for murdering four elderly patients and attempting to kill a fifth in Leeds hospitals. The case hinged on low blood sugar levels as evidence of insulin poisoning, and new reporting is asking whether the deaths could have had natural medical explanations instead, reopening debate over a possible miscarriage of justice.